Clinical significance of breakthrough phenomenon in liver transplant patients with recurrent hepatitis C treated with Interferon-ALPHA and Ribavirin.

被引：0
|
作者：
Nasir, A [1 ]
Smallwood, GA [1 ]
Stieber, AC [1 ]
Heffron, TG [1 ]
De Vera, ME [1 ]
机构：
[1] Emory Univ Hosp, Atlanta, GA 30322 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
418
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [31] IMPROVEMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS-C PATIENTS TREATED WITH NATURAL INTERFERON-ALPHA
    HIRAMATSU, N
    HAYASHI, N
    KASAHARA, A
    HAGIWARA, H
    TAKEHARA, T
    HARUNA, Y
    NAITO, M
    FUSAMOTO, H
    KAMADA, T
    [J]. JOURNAL OF HEPATOLOGY, 1995, 22 (02): : 135 - 142
  • [32] Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
    Rashed, Yasser K.
    Khalaf, Fatma A.
    Kotb, Sobhy E.
    [J]. CLINICAL AND EXPERIMENTAL PEDIATRICS, 2020, 63 (02) : 52 - 55
  • [33] Histopathologic assessment of post-orthotopic liver transplant (OLT) recurrent hepatitis c (HCV) in patients treated with pegylated interferon and ribavirin
    Martinez, AE
    Smallwood, GA
    Devine, RM
    Stieber, AC
    Heffron, TG
    Paner, GP
    Parkos, C
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 206 - 206
  • [34] Cytokine system in patients with chronic hepatitis C treated with interferon-alpha
    Ivashkin, VT
    Mammaev, SN
    Lukina, EA
    Lugovskaya, SA
    Shulpekova, YO
    Levina, AA
    Pochtar, ME
    [J]. TERAPEVTICHESKII ARKHIV, 2002, 74 (02): : 37 - 41
  • [35] Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
    Nadeem, Amina
    Hussain, Muhammad Mazhar
    Aslam, Muhammad
    Hussain, Tassawar
    [J]. HEPATITIS MONTHLY, 2010, 10 (02) : 132 - 140
  • [36] Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
    de Oliveira Andrade, Luis Jesuino
    Atta, Ajax Merces
    Brito de Sousa Atta, Maria Luiza
    Kalil Mangabeira, Celia Neder
    Parana, Raymundo
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (04): : 377 - 381
  • [37] Outcomes of treatment of hepatitis C cirrhosis with pegylated interferon-alpha and ribavirin
    Kong, J.
    Kontorinis, N.
    Studd, C.
    Tarquinio, L.
    Nazareth, S.
    McInerney, M.
    Cheng, W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A293 - A294
  • [38] Clinical relevance of anti-interferon antibodies in the serum of chronic hepatitis C patients treated with interferon-alpha
    Bonino, F
    Baldi, M
    Negro, F
    Oliveri, F
    Colombatto, P
    Bellati, G
    Brunetto, MR
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 : S35 - S38
  • [39] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [40] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433
12345